Photomedex (PHMD) 4.74 $PHMD
4 Stocks Under $10 Moving Higher Into Breakout Territory
at The Street - Fri Sep 19, 7:34AM CDT
Keep these under-$10 breakout stocks on your trading radar.
RIBT: 4.48 (-0.10), OPTT: 1.03 (unch), PHMD: 4.74 (+0.01), NSPH: 0.49 (-0.25)
GOOD, SAH, MKSI, PHMD Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Sep 15, 4:16AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Gladstone Commercial Corp (NASDAQ:GOOD), SONIC AUTOMOTIVE, INC. (NYSE:SAH), MKS Instruments Inc (NASDAQ:MKSI), PhotoMedex Inc (NASDAQ
HMD) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
GOOD: 17.10 (-0.02), PHMD: 4.74 (+0.01), MKSI: 33.35 (-0.16), SAH: 22.65 (+0.05)
Why PhotoMedex (PHMD) Stock Is Plummeting Today
at The Street - Thu Aug 07, 10:47AM CDT
PhotoMedex (PHMD) shares are down double digits on Thursday after reporting earnings and revenue below analysts expectations.
PHMD: 4.74 (+0.01)
New Independent Clinical Study of no!no! Hair Shows Substantial and Statistically Significant Reduction in Hair Regrowth on a Range of Skin Types and Hair Colors
Business Wire - Thu Aug 07, 6:45AM CDT
PhotoMedex, Inc. (NasdaqGS and TASE HMD) today announced that a new independent clinical study demonstrated a substantial reduction in hair regrowth following use of no!no! Hair using proprietary Thermicon(TM) technology. PhotoMedex's consumer products subsidiary Radiancy Inc. manufactures and sells the no!no! product line worldwide.
PHMD: 4.74 (+0.01)
PhotoMedex Reports Second Quarter Financial Results
Business Wire - Thu Aug 07, 6:30AM CDT
PhotoMedex, Inc. (NasdaqGS HMD) (TASE HMD) reports financial results for the three and six months ended June 30, 2014.
PHMD: 4.74 (+0.01)
MELA Sciences Names Michael R. Stewart to Board of Directors
GlobeNewswire - Tue Aug 05, 8:00AM CDT
MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind system, an optical diagnostic device approved for use in the U.S. and the European Union to assist dermatologists in melanoma diagnosis, today announced it has named Michael R. Stewart to its board of directors effective immediately. Mr. Stewart is an independent director.
MELA: 1.96 (-0.19), PHMD: 4.74 (+0.01)
PhotoMedex to Hold Second Quarter 2014 Conference Call on August 7th
Business Wire - Mon Aug 04, 12:35PM CDT
PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) will hold a conference call to discuss the Company's second quarter 2014 financial results on Thursday, August 7, 2014 at 8:30 a.m. Eastern Time.
PHMD: 4.74 (+0.01)
PhotoMedex breaks no!no! Hair Pro3 sales record in TV home shopping in the UK
M2 - Wed Mar 19, 8:33AM CDT
Skin health company PhotoMedex (NASDAQ HMD) (TASE HMD) declared on Tuesday that its no!no! Hair Pro3 broke another record of sales of more than 10,500 units for total retail sales exceeding GBP1.7m in a 24-hour special event on the major television home shopping channel in the UK.
PHMD: 4.74 (+0.01)
PhotoMedex Announces no!no! Hair Breaks Sales Record on U.K. TV Home Shopping, and Launch of Neova in U.K. Premium Retail
Business Wire - Tue Mar 18, 5:30AM CDT
PhotoMedex, Inc. (NASDAQ and TASE: PHMD) announces that last Saturday no!no!(TM) Hair Pro3 broke another beauty sales record when consumers purchased more than 10,500 units for total retail sales exceeding £1.7 million ($2.8 million) in a 24-hour special event on the major television home shopping channel in the U.K. This special event marked the television home shopping launch of the newly revealed no!no! Hair Pro3 model.
PHMD: 4.74 (+0.01)
PhotoMedex posts lower net income of USD18.4m in 2013
M2 - Fri Mar 14, 7:10AM CDT
Skin health company PhotoMedex (NASDAQ HMD)(TASE HMD) stated on Thursday its net income USD18.4m (USD0.89 per diluted share) for the full year ended 31 December 2013.
PHMD: 4.74 (+0.01)
PhotoMedex Reports Record Revenues for the 2013 Fourth Quarter and Full Year
Business Wire - Thu Mar 13, 5:00AM CDT
PhotoMedex, Inc. (NASDAQ and TASE HMD) today announced financial results for the fourth quarter and full year ended December 31, 2013. Financial highlights include:
PHMD: 4.74 (+0.01)
Investors are betting against PhotoMedex (PHMD), Should You? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 9:27AM CDT
Investors are betting against PhotoMedex (PHMD), Should You?
PHMD: 4.74 (+0.01)
PhotoMedex to Hold Fourth Quarter 2013 Conference Call on March 13th
Business Wire - Wed Mar 05, 7:30AM CST
PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) will hold a conference call to discuss the Company's fourth quarter 2013 financial results on Thursday, March 13, 2014 at 11:00 a.m. Eastern Time.
PHMD: 4.74 (+0.01)
PhotoMedex Appoints Trevor S. Harris to Its Board of Directors
Business Wire - Tue Mar 04, 7:30AM CST
PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) announces the appointment of Trevor S. Harris, Ph.D., CA (SA) to the Company's board of directors, returning the board's size to eight members. Effective April 1, 2014, Dr. Harris will also serve as chairman of the Company's audit committee. He replaces Dr. Nahum Melumad, who passed away on January 15, 2014.
PHMD: 4.74 (+0.01)
Brower Piven Announces Class Action Lawsuit in Connection With Claims of Breaches of Fiduciary Duty by the Board of Directors of LCA-Vision, Inc. in Connection With the Sale of the Company to PhotoMedex, Inc. -- LCAV
GlobeNewswire - Fri Feb 21, 1:13PM CST
The securities litigation firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in Delaware state court on behalf of all common stockholders of LCA-Vision, Inc. ("LCA" or the "Company"
(Nasdaq:LCAV).
LCAV: 5.37 (unch), PHMD: 4.74 (+0.01)
INVESTOR ALERT: LEVI & KORSINSKY, LLP Notifies Investors of LCA-VISION INC. of Class Action Against Its Board of Directors in Connection With the Sale of the Company to PhotoMedex, Inc. -- LCAV
GlobeNewswire - Fri Feb 21, 12:28PM CST
Levi & Korsinsky notifies investors of LCA-Vision Inc. ("LCA" or "the Company" (Nasdaq:LCAV) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to PhotoMedex, Inc. (Nasdaq HMD). A complaint was filed in Delaware state court.
LCAV: 5.37 (unch), PHMD: 4.74 (+0.01)
INVESTOR ALERT - LCA-VISION INC.: The Law Offices of Vincent Wong Investigates the Sale of LCA-Vision Inc. to PhotoMedex, Inc. -- LCAV
Business Wire - Fri Feb 21, 12:11PM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of LCA-Vision Inc. (NasdaqGS:LCAV) ("LCA-Vision" in connection with the sale of the Company to PhotoMedex, Inc.
LCAV: 5.37 (unch), PHMD: 4.74 (+0.01), NVTL: 2.56 (+0.02)
INVESTOR ALERT - LCA-VISION INC.: The Law Offices of Vincent Wong Investigates the Sale of LCA-Vision Inc. to PhotoMedex, Inc.
Business Wire - Wed Feb 19, 12:31PM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of LCA-Vision Inc. (NasdaqGS:LCAV) ("LCA-Vision" in connection with the sale of the Company to PhotoMedex, Inc.
LCAV: 5.37 (unch), PHMD: 4.74 (+0.01)
PhotoMedex to Present at 2014 RBC Capital Markets' Healthcare Conference on February 26
Business Wire - Wed Feb 19, 8:00AM CST
PhotoMedex, Inc. (NASDAQ and TASE: PHMD) today announced that Dennis McGrath, president and chief financial officer, will present at the 2014 RBC Capital Markets Healthcare Conference on Wednesday, February 26th at 11:30 a.m. Eastern time. The presentation will provide a corporate overview and a discussion of the Company's growth strategy. The conference will be held at the New York Palace Hotel in New York City.
PHMD: 4.74 (+0.01)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of LCA-VISION INC. and Its Board of Directors In Connection With the Sale of the Company to PhotoMedex, Inc. -- LCAV
PR Newswire - Tue Feb 18, 11:42AM CST
Levi & Korsinsky commenced an investigation of the Board of Directors of LCA-Vision Inc. ("LCA" or "the Company" (NasdaqGS: LCAV) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to PhotoMedex, Inc. (NasdaqGS: PHMD).
LCAV: 5.37 (unch), PHMD: 4.74 (+0.01)
4 Stocks Under $10 Moving Higher Into Breakout Territory
at The Street - Fri Sep 19, 7:34AM CDT
Keep these under-$10 breakout stocks on your trading radar.
RIBT: 4.48 (-0.10), OPTT: 1.03 (unch), PHMD: 4.74 (+0.01), NSPH: 0.49 (-0.25)
GOOD, SAH, MKSI, PHMD Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Sep 15, 4:16AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Gladstone Commercial Corp (NASDAQ:GOOD), SONIC AUTOMOTIVE, INC. (NYSE:SAH), MKS Instruments Inc (NASDAQ:MKSI), PhotoMedex Inc (NASDAQ
HMD) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: GOOD: 17.10 (-0.02), PHMD: 4.74 (+0.01), MKSI: 33.35 (-0.16), SAH: 22.65 (+0.05)
Why PhotoMedex (PHMD) Stock Is Plummeting Today
at The Street - Thu Aug 07, 10:47AM CDT
PhotoMedex (PHMD) shares are down double digits on Thursday after reporting earnings and revenue below analysts expectations.
PHMD: 4.74 (+0.01)
New Independent Clinical Study of no!no! Hair Shows Substantial and Statistically Significant Reduction in Hair Regrowth on a Range of Skin Types and Hair Colors
Business Wire - Thu Aug 07, 6:45AM CDT
PhotoMedex, Inc. (NasdaqGS and TASE
HMD) today announced that a new independent clinical study demonstrated a substantial reduction in hair regrowth following use of no!no! Hair using proprietary Thermicon(TM) technology. PhotoMedex's consumer products subsidiary Radiancy Inc. manufactures and sells the no!no! product line worldwide. PHMD: 4.74 (+0.01)
PhotoMedex Reports Second Quarter Financial Results
Business Wire - Thu Aug 07, 6:30AM CDT
PhotoMedex, Inc. (NasdaqGS
HMD) (TASE HMD) reports financial results for the three and six months ended June 30, 2014. PHMD: 4.74 (+0.01)
MELA Sciences Names Michael R. Stewart to Board of Directors
GlobeNewswire - Tue Aug 05, 8:00AM CDT
MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind system, an optical diagnostic device approved for use in the U.S. and the European Union to assist dermatologists in melanoma diagnosis, today announced it has named Michael R. Stewart to its board of directors effective immediately. Mr. Stewart is an independent director.
MELA: 1.96 (-0.19), PHMD: 4.74 (+0.01)
PhotoMedex to Hold Second Quarter 2014 Conference Call on August 7th
Business Wire - Mon Aug 04, 12:35PM CDT
PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) will hold a conference call to discuss the Company's second quarter 2014 financial results on Thursday, August 7, 2014 at 8:30 a.m. Eastern Time.
PHMD: 4.74 (+0.01)
PhotoMedex breaks no!no! Hair Pro3 sales record in TV home shopping in the UK
M2 - Wed Mar 19, 8:33AM CDT
Skin health company PhotoMedex (NASDAQ
HMD) (TASE HMD) declared on Tuesday that its no!no! Hair Pro3 broke another record of sales of more than 10,500 units for total retail sales exceeding GBP1.7m in a 24-hour special event on the major television home shopping channel in the UK. PHMD: 4.74 (+0.01)
PhotoMedex Announces no!no! Hair Breaks Sales Record on U.K. TV Home Shopping, and Launch of Neova in U.K. Premium Retail
Business Wire - Tue Mar 18, 5:30AM CDT
PhotoMedex, Inc. (NASDAQ and TASE: PHMD) announces that last Saturday no!no!(TM) Hair Pro3 broke another beauty sales record when consumers purchased more than 10,500 units for total retail sales exceeding £1.7 million ($2.8 million) in a 24-hour special event on the major television home shopping channel in the U.K. This special event marked the television home shopping launch of the newly revealed no!no! Hair Pro3 model.
PHMD: 4.74 (+0.01)
PhotoMedex posts lower net income of USD18.4m in 2013
M2 - Fri Mar 14, 7:10AM CDT
Skin health company PhotoMedex (NASDAQ
HMD)(TASE HMD) stated on Thursday its net income USD18.4m (USD0.89 per diluted share) for the full year ended 31 December 2013. PHMD: 4.74 (+0.01)
PhotoMedex Reports Record Revenues for the 2013 Fourth Quarter and Full Year
Business Wire - Thu Mar 13, 5:00AM CDT
PhotoMedex, Inc. (NASDAQ and TASE
HMD) today announced financial results for the fourth quarter and full year ended December 31, 2013. Financial highlights include: PHMD: 4.74 (+0.01)
Investors are betting against PhotoMedex (PHMD), Should You? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 9:27AM CDT
Investors are betting against PhotoMedex (PHMD), Should You?
PHMD: 4.74 (+0.01)
PhotoMedex to Hold Fourth Quarter 2013 Conference Call on March 13th
Business Wire - Wed Mar 05, 7:30AM CST
PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) will hold a conference call to discuss the Company's fourth quarter 2013 financial results on Thursday, March 13, 2014 at 11:00 a.m. Eastern Time.
PHMD: 4.74 (+0.01)
PhotoMedex Appoints Trevor S. Harris to Its Board of Directors
Business Wire - Tue Mar 04, 7:30AM CST
PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) announces the appointment of Trevor S. Harris, Ph.D., CA (SA) to the Company's board of directors, returning the board's size to eight members. Effective April 1, 2014, Dr. Harris will also serve as chairman of the Company's audit committee. He replaces Dr. Nahum Melumad, who passed away on January 15, 2014.
PHMD: 4.74 (+0.01)
Brower Piven Announces Class Action Lawsuit in Connection With Claims of Breaches of Fiduciary Duty by the Board of Directors of LCA-Vision, Inc. in Connection With the Sale of the Company to PhotoMedex, Inc. -- LCAV
GlobeNewswire - Fri Feb 21, 1:13PM CST
The securities litigation firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in Delaware state court on behalf of all common stockholders of LCA-Vision, Inc. ("LCA" or the "Company"
(Nasdaq:LCAV). LCAV: 5.37 (unch), PHMD: 4.74 (+0.01)
INVESTOR ALERT: LEVI & KORSINSKY, LLP Notifies Investors of LCA-VISION INC. of Class Action Against Its Board of Directors in Connection With the Sale of the Company to PhotoMedex, Inc. -- LCAV
GlobeNewswire - Fri Feb 21, 12:28PM CST
Levi & Korsinsky notifies investors of LCA-Vision Inc. ("LCA" or "the Company"
(Nasdaq:LCAV) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to PhotoMedex, Inc. (Nasdaq HMD). A complaint was filed in Delaware state court. LCAV: 5.37 (unch), PHMD: 4.74 (+0.01)
INVESTOR ALERT - LCA-VISION INC.: The Law Offices of Vincent Wong Investigates the Sale of LCA-Vision Inc. to PhotoMedex, Inc. -- LCAV
Business Wire - Fri Feb 21, 12:11PM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of LCA-Vision Inc. (NasdaqGS:LCAV) ("LCA-Vision"
in connection with the sale of the Company to PhotoMedex, Inc. LCAV: 5.37 (unch), PHMD: 4.74 (+0.01), NVTL: 2.56 (+0.02)
INVESTOR ALERT - LCA-VISION INC.: The Law Offices of Vincent Wong Investigates the Sale of LCA-Vision Inc. to PhotoMedex, Inc.
Business Wire - Wed Feb 19, 12:31PM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of LCA-Vision Inc. (NasdaqGS:LCAV) ("LCA-Vision"
in connection with the sale of the Company to PhotoMedex, Inc. LCAV: 5.37 (unch), PHMD: 4.74 (+0.01)
PhotoMedex to Present at 2014 RBC Capital Markets' Healthcare Conference on February 26
Business Wire - Wed Feb 19, 8:00AM CST
PhotoMedex, Inc. (NASDAQ and TASE: PHMD) today announced that Dennis McGrath, president and chief financial officer, will present at the 2014 RBC Capital Markets Healthcare Conference on Wednesday, February 26th at 11:30 a.m. Eastern time. The presentation will provide a corporate overview and a discussion of the Company's growth strategy. The conference will be held at the New York Palace Hotel in New York City.
PHMD: 4.74 (+0.01)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of LCA-VISION INC. and Its Board of Directors In Connection With the Sale of the Company to PhotoMedex, Inc. -- LCAV
PR Newswire - Tue Feb 18, 11:42AM CST
Levi & Korsinsky commenced an investigation of the Board of Directors of LCA-Vision Inc. ("LCA" or "the Company"
(NasdaqGS: LCAV) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to PhotoMedex, Inc. (NasdaqGS: PHMD). LCAV: 5.37 (unch), PHMD: 4.74 (+0.01)
